Brigit Biofarmaka Teknologi Tbk. vs Kedoya Adyaraya Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Kedoya Adyaraya Tbk. trades at Rp1,000 (market cap 957.57B, 29K 24h volume). The key difference: Kedoya Adyaraya Tbk. is far larger — about 5.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 29K). Which is the better fit depends on your goals.
| OBAT | RSGK | |
|---|---|---|
Market Cap | 172.82B | 957.57B |
Volume | 592.2K | 29K |
Lot | 5.92K | 290 |
Turnover | 147.05M | 28.96M |
Average Price | 248.31 | 998.62 |
Value | 147.05M | 28.96M |
Indicative Equilibrium Price | 254 | 1,000 |
Indicative Equilibrium Volume | 10 | 52 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.
Read more on RSGK →